References

References: Science in Detail 1 · The Story, Retold in Full Mechanism

  1. Vizcaino E, Grimalt JO, Fernandez-Somoano A, Tardon A, Transport of persistent organic pollutants across the human placenta, Environ Int 65:107-115, 2014 (PMID 24486968)
  2. Needham LL et al., Partition of environmental chemicals between maternal and fetal blood and tissues, Environ Sci Technol 45(3):1121-1126, 2011 (PMID 21166449)
  3. Mangelsdorf DJ et al., 'The nuclear receptor superfamily: the second decade,' Cell 83(6):835-839, 1995.
  4. Alberts B et al., 'Molecular Biology of the Cell,' 6th ed., Garland Science, 2014 (cell-signalling amplification).
  5. Norman AW & Henry HL, 'Hormones,' 3rd ed., Academic Press, 2015.
  6. Welshons WV et al. (2003). Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environmental Health Perspectives, 111(8), 994-1006.
  7. Vandenberg LN et al. (2012). Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews, 33(3), 378-455.
  8. Nilsson S, et al. Mechanisms of estrogen action. Physiological Reviews 81(4):1535-1565, 2001.
  9. Heldring N, et al. Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 87(3):905-931, 2007.
  10. Gore AC et al., 'EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals,' Endocrine Reviews 36(6):E1-E150, 2015.
  11. Vandenberg LN et al., 'Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses,' Endocrine Reviews 33(3):378-455, 2012.
  12. University of Rochester Medical Center, Health Encyclopedia, 'Estradiol (Blood)' - normal ranges in pg/mL.
  13. Vandenberg LN et al., Endocrine Reviews 33(3):378-455, 2012.
  14. University of Rochester Medical Center, Health Encyclopedia. Estradiol (Blood).
  15. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33(3):378-455, 2012.
  16. Heindel JJ, Newbold RR, Bucher JR, et al. NIEHS/FDA CLARITY-BPA research program update. Reproductive Toxicology 58:33–44 (2015).
  17. vom Saal FS, Welshons WV. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environmental Research 100(1):50–76 (2006).
  18. Sekido R & Lovell-Badge R, 'Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer,' Nature 453(7197):930-934, 2008.
  19. Wilhelm D, Palmer S, Koopman P, Physiological Reviews 87(1):1-28, 2007.
  20. Rey R & Grinspon RP, Best Pract Res Clin Endocrinol Metab 25(2):221-238, 2011.
  21. Koopman P, 'The genetics and biology of vertebrate sex determination,' Cell 105(7):843-847, 2001.
  22. Sekido R & Lovell-Badge R, Nature 453(7197):930-934, 2008.
  23. Koopman P, Cell 105(7):843-847, 2001.
  24. Berta P, Hawkins JR, Sinclair AH, et al., 'Genetic evidence equating SRY and the testis-determining factor,' Nature 348:448-450, 1990.
  25. Jager RJ, Anvret M, Hall K, Scherer G, 'A human XY female with a frame shift mutation in the candidate testis-determining gene SRY,' Nature 348(6300):452-454, 1990.
  26. Jost A. Recherches sur la differenciation sexuelle de l'embryon de lapin. Arch Anat Microsc Morphol Exp. 1947;36:271-315.
  27. Sinclair AH et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990;346(6281):240-244.
  28. Wilhelm D, Palmer S, Koopman P. Sex determination and gonadal development in mammals. Physiol Rev. 2007;87(1):1-28.
  29. Jost A. 'A new look at the mechanisms controlling sex differentiation in mammals.' Johns Hopkins Medical Journal 130(1):38-53, 1972.
  30. Hughes IA. 'Minireview: sex differentiation.' Endocrinology 142(8):3281-3287, 2001.
  31. Jost A, Phil Trans R Soc Lond B 259:119-130, 1970.
  32. Wilhelm D, Palmer S, Koopman P, Physiol Rev 87(1):1-28, 2007.
  33. Phoenix CH, Goy RW, Gerall AA, Young WC, 'Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig,' Endocrinology 65:369-382, 1959.
  34. Arnold AP, 'The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues,' Hormones and Behavior 55(5):570-578, 2009.
  35. Arnold AP. "The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation." Hormones and Behavior 55(5):570-578, 2009.
  36. Phoenix CH, Goy RW, Gerall AA, Young WC, 'Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig,' Endocrinology 65(3):369-382, 1959.
  37. Arnold AP, 'The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues,' Horm Behav 55(5):570-578, 2009.
  38. Arnold AP, 'The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation,' Hormones and Behavior 64(5):570-580, 2013.
  39. McCarthy MM, De Vries GJ, Forger NG, 'Sexual differentiation of the brain: A fresh look at mode, mechanisms, and meaning,' in Hormones, Brain and Behavior, 3rd ed., Academic Press, 2017.
  40. McCarthy MM, Nugent BM, 'Epigenetic contributions to hormonally-mediated sexual differentiation of the brain,' Journal of Neuroendocrinology 25(11):1133-1140, 2013.
  41. Forger NG, 'Epigenetic mechanisms in sexual differentiation of the brain and behaviour,' Philosophical Transactions of the Royal Society B 371(1688):20150114, 2016.
  42. Schulz KM, Sisk CL. (2016). The organizing actions of adolescent gonadal steroid hormones on brain and behavioral development. Neuroscience & Biobehavioral Reviews, 70, 148-158.
  43. Sisk CL, Foster DL. (2004). The neural basis of puberty and adolescence. Nature Neuroscience, 7(10), 1040-1047.
  44. Phoenix CH, Goy RW, Gerall AA, Young WC. (1959). Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology, 65, 369-382.
  45. Arnold AP. (2009). The organizational-activational hypothesis... Hormones and Behavior, 55(5), 570-578.
  46. Bao AM, Swaab DF. (2011). Sexual differentiation of the human brain. Frontiers in Neuroendocrinology, 32(2), 214-226.
  47. Wilson JD, Griffin JE, Russell DW, 'Steroid 5 alpha-reductase 2 deficiency,' Endocrine Reviews 14(5):577-593, 1993.
  48. Imperato-McGinley J, Zhu YS, 'Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency,' Molecular and Cellular Endocrinology 198(1-2):51-59, 2002.
  49. Hughes IA et al. Androgen insensitivity syndrome. Lancet. 2012;380(9851):1419-1428.
  50. Imperato-McGinley J et al. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213-1215.
  51. Welsh M et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008;118(4):1479-1490.
  52. McCarthy MM. Estradiol and the developing brain. Physiol Rev. 2008;88(1):91-124.
  53. Naftolin F, Ryan KJ, Davies IJ, et al. The formation of estrogens by central neuroendocrine tissues. Recent Prog Horm Res. 1975;31:295-319.
  54. Thornton JW. PNAS 98(10):5671-5676, 2001.
  55. Baker ME. Molecular and Cellular Endocrinology 135(2):101-107, 1997.
  56. McCarthy MM. "Estradiol and the developing brain." Physiological Reviews 88(1):91-124, 2008.
  57. Lephart ED. "A review of brain aromatase cytochrome P450." Brain Research Reviews 22(1):1-26, 1996.
  58. Crump KL, Trudeau VL. "Mercury-induced reproductive impairment in fish." Environmental Toxicology and Chemistry 28(5):895-907, 2009.
  59. Tan SW, Meiller JC, Mahaffey KR. "The endocrine effects of mercury in humans and wildlife." Crit Rev Toxicol 39(3):228-269, 2009.
  60. Jayasena N, Frederick PC, Larkin ILV. "Endocrine disruption in white ibises (Eudocimus albus) caused by exposure to environmentally relevant levels of methylmercury." Aquatic Toxicology 105(3-4):321-327, 2011.
  61. Matthiessen P, Gibbs PE. Critical appraisal of the evidence for tributyltin-mediated endocrine disruption in mollusks. Environ Toxicol Chem. 1998;17(1):37-43.
  62. Santos MM, Castro LFC, Vieira MN, et al. New insights into the mechanism of imposex induction in the dogwhelk Nucella lapillus. Comp Biochem Physiol C. 2005;141(1):101-109.
  63. Quigley CA et al., 'Androgen receptor defects: historical, clinical, and molecular perspectives,' Endocr Rev 16(3):271-321, 1995.
  64. Mongan NP et al., Best Pract Res Clin Endocrinol Metab 29(4):569-580, 2015.
  65. Wilson JD, Griffin JE, Russell DW, 'Steroid 5alpha-reductase 2 deficiency,' Endocr Rev 14(5):577-593, 1993.
  66. Rey R & Grinspon RP, 'Normal male sexual differentiation and aetiology of disorders of sex development,' Best Pract Res Clin Endocrinol Metab 25(2):221-238, 2011.
  67. Imperato-McGinley J et al., 'Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism,' Science 186(4170):1213-1215, 1974.
  68. Simpson ER et al., 'Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis,' Endocr Rev 15(3):342-355, 1994.
  69. Harada N, 'Aromatase and sex steroid action,' Nat Rev Mol Cell Biol 2(2):139-148, 2001.
  70. Rich et al., 'The Increasing Prevalence in Intersex Variation from Toxicological Dysregulation in Fetal Reproductive Tissue Differentiation and Development by Endocrine-Disrupting Chemicals,' Environ Health Insights 2016
  71. 'Estrogenic and anti-androgenic endocrine disrupting chemicals and their impact on the male reproductive system,' Frontiers in Environmental Science 2015
  72. 'Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men,' Front. Endocrinol. 2021 (PMC8530230)
  73. Roselli CE, Liu M, Hurn PD, 'Brain aromatization: classic roles and new perspectives,' Seminars in Reproductive Medicine 27(3):207-217, 2009.
  74. Naftolin F, Ryan KJ, Davies IJ, et al., 'The formation of estrogens by central neuroendocrine tissues,' Recent Progress in Hormone Research 31:295-319, 1975.
  75. MedlinePlus Genetics, SRD5A2 gene. U.S. National Library of Medicine.
  76. Biochemistry, Dihydrotestosterone. StatPearls, NCBI Bookshelf (NBK557634).
  77. 5-alpha reductase deficiency, MedlinePlus Genetics.
  78. Hines M. Early androgen exposure and human gender development. Biol Sex Differ. 2015;6:3.
  79. MacLusky NJ, Naftolin F. Sexual differentiation of the central nervous system. Science 211(4488):1294-1303, 1981.
  80. Fan W et al. Atrazine-induced aromatase expression is SF-1 dependent: implications for endocrine disruption in wildlife and reproductive cancers in humans. Environmental Health Perspectives 115(5):720-727, 2007.
  81. Cooper RL et al. Atrazine and reproductive function: mode and mechanism of action studies. Birth Defects Research Part B 80(2):98-112, 2007.
  82. Hayes TB et al. Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecologically relevant doses. PNAS 99(8):5476-5480, 2002.
  83. Sanderson JT et al. 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells. Toxicological Sciences 54(1):121-127, 2000.
  84. MedlinePlus Genetics: CYP19A1 gene. U.S. National Library of Medicine.
  85. Simpson ER et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews 15(3):342-355, 1994.
  86. Roselli CE et al. Brain aromatization: classic roles and new perspectives. Seminars in Reproductive Medicine 27(3):207-217, 2009.
  87. Balthazart J, Ball GF. New insights into the regulation and function of brain estrogen synthase (aromatase). Trends in Neurosciences 21(6):243-249, 1998.
  88. Naftolin F, Horvath TL, Jakab RL, Leranth C, Harada N, Balthazart J. (1996). Aromatase immunoreactivity in axon terminals of the vertebrate brain. Neuroendocrinology, 63(2), 149-155.
  89. Roselli CE, Liu M, Hurn PD. (2009). Brain aromatization: classic roles and new perspectives. Seminars in Reproductive Medicine, 27(3), 207-217.
  90. Cao J, Joyner L, Mickens JA, Leyrer SM, Patisaul HB. (2013). Sex-specific Esr2 mRNA expression in the rat hypothalamus and amygdala is altered by neonatal bisphenol A exposure. (Patisaul lab, NCSU). Toxicological Sciences / Reproduction.
  91. Patisaul HB et al. — full text confirming NCSU authorship and hypothalamus/amygdala findings.
  92. Sanderson JT, Seinen W, Giesy JP, van den Berg M. (2000). 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells. Toxicological Sciences, 54(1), 121-127.
  93. Hayes TB, et al. (2011). Demasculinization and feminization of male gonads by atrazine: consistent effects across vertebrate classes. Journal of Steroid Biochemistry and Molecular Biology, 127(1-2), 64-73.
  94. Stocco C. (2008). Aromatase expression in the ovary: hormonal and molecular regulation. Steroids, 73(5), 473-487.
  95. Simpson ER, Clyne C, Rubin G, et al. (2002). Aromatase — a brief overview. Annual Review of Physiology, 64, 93-127.
  96. Wilson JD, George FW, Griffin JE, 'The hormonal control of sexual development,' Science 211(4488):1278-1284, 1981.
  97. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213-1215.
  98. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency. N Engl J Med. 1979;300(22):1233-1237.
  99. 'güevedoce,' Wiktionary
  100. 'Güevedoce' (Huevo a los doce), Wikipedia
  101. Anthony Rivas, 'Guevedoces In Dominican Republic Don't Grow Penises Until Age 12,' Medical Daily
  102. Imperato-McGinley, Guerrero, Gautier & Peterson, 'Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism,' Science 186(4170):1213 (1974)
  103. Thigpen et al., 'The molecular basis of steroid 5α-reductase deficiency in a large Dominican kindred,' NEJM 327:1216 (1992)
  104. 'Las Salinas, The Village Where Girls Become Boys,' The Guardian (Nigeria)
  105. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. NEJM. 1979;300(22):1233-1237.
  106. Cohen-Kettenis PT. Arch Sex Behav. 2005;34(4):399-410.
  107. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man. Science. 1974;186(4170):1213-1215.
  108. Maimoun L, Philibert P, Cammas B, et al. Phenotypical, biological, and molecular heterogeneity of 5alpha-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab. 2011;96(2):296-307.
  109. Cohen-Kettenis PT. Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav. 2005;34(4):399-410.
  110. Maimoun L, et al. J Clin Endocrinol Metab. 2011;96(2):296-307.
  111. BBC News, 'The extraordinary case of the Guevedoces,' 2015.
  112. Hughes IA et al., 'Consensus statement on management of intersex disorders,' Arch Dis Child 91(7):554-563, 2006.
  113. Quigley CA et al., Endocr Rev 16(3):271-321, 1995.
  114. Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M, 'The androgen receptor gene mutations database: 2012 update,' Hum Mutat 33(5):887-894, 2012.
  115. Hughes IA et al., Arch Dis Child 91(7):554-563, 2006.
  116. Mongan NP, Tadokoro-Cuccaro R, Bunch T, Hughes IA, 'Androgen insensitivity syndrome,' Best Pract Res Clin Endocrinol Metab 29(4):569-580, 2015.
  117. Hughes IA et al., Arch Dis Child 91:554-563, 2006.
  118. Mongan NP et al., 'Androgen insensitivity syndrome,' Best Pract Res Clin Endocrinol Metab 29(4):569-580, 2015.
  119. Charlesworth B & Charlesworth D, 'The degeneration of Y chromosomes,' Philos Trans R Soc Lond B Biol Sci 355(1403):1563-1572, 2000.
  120. Bachtrog D, 'Y-chromosome evolution: emerging insights into processes of Y-chromosome degeneration,' Nat Rev Genet 14(2):113-124, 2013.
  121. Martinez-Patino MJ, Lancet 366:S38, 2005.
  122. Hughes IA, Houk C, Ahmed SF, Lee PA, 'Consensus statement on management of intersex disorders,' Archives of Disease in Childhood 91(7):554-563, 2006.
  123. Hannema SE, Hughes IA, 'Regulation of Wolffian duct development,' Hormone Research 67(3):142-151, 2007.
  124. Hines M, Ahmed SF, Hughes IA. Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav 32(2):93-101, 2003.
  125. Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J. Androgen insensitivity syndrome. Lancet 380(9851):1419-1428, 2012.
  126. Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J. Androgen insensitivity syndrome. Lancet. 2012;380(9851):1419-1428.
  127. NIH/MedlinePlus Genetics: Androgen insensitivity syndrome.
  128. Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M. The androgen receptor gene mutations database. Hum Mutat. 2012;33(5):887-894.
  129. Hughes IA, Davies JD, Bunch TI, et al. Androgen insensitivity syndrome. Lancet 380(9851):1419-1428, 2012.
  130. Gottlieb B, Beitel LK, Nadarajah A, Paliouras M, Trifiro M. The androgen receptor gene mutations database: 2012 update. Human Mutation 33(5):887-894, 2012.
  131. Patel, K., M. Gauttam, and M. Baria. 'Therapeutic Potential of Diosgenin: A Review.' (2012); see also ACS National Historic Chemical Landmark, Marker Degradation.
  132. Djerassi, Carl. 'Steroid Research at Syntex: The Pill and Progesterone.' Steroids 57, no. 12 (1992): 631–641.
  133. Raynaud JP, Mercier-Bodard C, Baulieu EE, 'Rat estradiol binding plasma protein (EBP),' Steroids 18(6):767-788, 1971.
  134. Bakker J et al., 'Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens,' Nat Neurosci 9(2):220-226, 2006.
  135. Bakker J & Baum MJ, 'Role for estradiol in female-typical brain and behavioral sexual differentiation,' Front Neuroendocrinol 29(1):1-16, 2008.
  136. McCarthy MM, 'Estradiol and the developing brain,' Physiol Rev 88(1):91-124, 2008.
  137. Bakker J, De Mees C, Douhard Q, et al., 'Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens,' Nature Neuroscience 9(2):220-226, 2006.
  138. McCarthy MM, 'Estradiol and the developing brain,' Physiological Reviews 88(1):91-134, 2008.
  139. Milligan SR, Khan O, Nash M. Competitive binding of xenobiotic oestrogens to rat alpha-fetoprotein and to sex steroid binding proteins in human and rainbow trout (Oncorhynchus mykiss) plasma. Gen Comp Endocrinol 112(1):89-95, 1998.
  140. Nagel SC, vom Saal FS, Thayer KA, Dhar MG, Boechler M, Welshons WV. Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol. Environ Health Perspect 105(1):70-76, 1997.
  141. Sulemanji M, Vakili K. Neonatal renal physiology. Semin Pediatr Surg 22(4):195-198, 2013.
  142. Solhaug MJ, Bolger PM, Jose PA. The developing kidney and environmental toxins. Pediatrics 113(4 Suppl):1084-1091, 2004.
  143. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33(3):378-455.
  144. Bakker J, et al. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nat Neurosci. 2006;9(2):220-226.
  145. Vallette G, et al. / Localization of the estrogen-binding site of alpha-fetoprotein using chimeric human-rat proteins. PNAS.
  146. Bakker J et al. Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nature Neuroscience 9(2):220-226, 2006.
  147. De Mees C et al. Alpha-fetoprotein controls female fertility and prenatal development of the gonadotropin-releasing hormone pathway through an antiestrogenic action. Molecular and Cellular Biology 26(5):2012-2018, 2006.
  148. Bakker J, De Mees C, Douhard Q, et al. (2006). Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens. Nature Neuroscience, 9(2), 220-226.
  149. Csaba G, Karabelyos C. (1997). Flavonoids inhibit estrogen binding to rat alpha-fetoprotein. Life Sciences, 60(25), 2361-2368.
  150. Rey R & Grinspon RP, Best Practice & Research Clinical Endocrinology & Metabolism 25(2):221-238, 2011.
  151. Blair RM, Fang H, Branham WS, et al. The estrogen receptor relative binding affinities of 188 natural and xenochemicals. Toxicological Sciences 54(1):138-153, 2000.
  152. Korach KS. Diethylstilbestrol metabolites and analogs. J Biol Chem 254(18):8963-8968, 1979.
  153. Jobling S, Nolan M, Tyler CR, Brighty G, Sumpter JP. 'Widespread Sexual Disruption in Wild Fish.' Environmental Science & Technology 32(17):2498-2506 (1998).
  154. Jobling S, et al. 'Predicted Exposures to Steroid Estrogens in U.K. Rivers Correlate with Widespread Sexual Disruption in Wild Fish Populations.' Environmental Health Perspectives 114(S-1):32-39 (2006).
  155. Bakker J, Baum MJ. 'Role for estradiol in female-typical brain and behavioral sexual differentiation.' Frontiers in Neuroendocrinology 29(1):1-16, 2008. doi:10.1016/j.yfrne.2007.06.001. PMID 17720235. [ARGUES ESTRADIOL IS REQUIRED POSTNATALLY; previously mis-filed as supporting the opposite]
  156. Bakker J, De Mees C, Douhard Q, et al. 'Alpha-fetoprotein protects the developing female mouse brain from masculinization and defeminization by estrogens.' Nature Neuroscience 9(2):220-226, 2006. doi:10.1038/nn1624. [AFP shield, prenatal]
  157. Thalidomide scandal — Wikipedia (citing multiple historical studies).
  158. Vargesson N, Birth Defects Research C 105(2): 140–156, 2015.
  159. Saper CB, Lowell BB. The hypothalamus. Curr Biol. 2014;24(23):R1111-R1116.
  160. Bear MF, Connors BW, Paradiso MA. Neuroscience: Exploring the Brain, 5th ed. Wolters Kluwer; 2020.
  161. Melmed S et al. (2020). Williams Textbook of Endocrinology, 14th ed. Elsevier.
  162. Hall JE, Hall ME (2020). Guyton and Hall Textbook of Medical Physiology, 14th ed. Elsevier.
  163. Hines M. 'Sex-related variation in human behavior and the brain.' Trends in Cognitive Sciences 14(10):448-456, 2010.
  164. Berenbaum SA, Beltz AM. 'Sexual differentiation of human behavior: Effects of prenatal and pubertal organizational hormones.' Frontiers in Neuroendocrinology 32(2):183-200, 2011.
  165. MacLusky NJ & Naftolin F, 'Sexual differentiation of the central nervous system,' Science 211(4488):1294-1302, 1981.
  166. Roselli CE et al., 'Estrogen synthesis in the brain - a role in sexual differentiation and reproductive behaviors,' Endocr Rev 30(4):343-375, 2009.
  167. Gooren L, 'The biology of human psychosexual differentiation,' Horm Behav 50(4):589-601, 2006.
  168. Aromatase deficiency, MedlinePlus Genetics (NIH).
  169. Sanderson JT, 'The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals,' Toxicol Sci 94(1):3-21, 2006.
  170. Fan W et al., 'Atrazine-induced aromatase expression is SF-1 dependent...,' Environ Health Perspect 115(5):720-727, 2007.
  171. McEwen BS, 'Permanence of brain sex differences and structural plasticity of the adult brain,' Proc Natl Acad Sci USA 96(13):7128-7130, 1999.
  172. Hines M, 'Early androgen exposure and human gender development,' Biology of Sex Differences 6:3, 2015.
  173. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE, 'Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism,' Science 186(4170):1213-1215, 1974.
  174. Reyes FI, Boroditsky RS, Winter JS, Faiman C, 'Studies on human sexual development. II. Fetal and maternal serum gonadotropin and sex steroid concentrations,' Journal of Clinical Endocrinology and Metabolism 38(4):612-617, 1974.
  175. Tapanainen J, Kellokumpu-Lehtinen P, Pelliniemi L, Huhtaniemi I, 'Age-related changes in endogenous steroids of human fetal testis during early and midpregnancy,' Journal of Clinical Endocrinology and Metabolism 52(1):98-102, 1981.
  176. Jost A. 'A new look at the mechanisms controlling sex differentiation in mammals.' Johns Hopkins Med J 130(1):38-53, 1972.
  177. Swaab DF. 'Sexual differentiation of the brain and behavior.' Best Pract Res Clin Endocrinol Metab 21(3):431-444, 2007.
  178. Naftolin F et al. The formation of estrogens by central neuroendocrine tissues. Recent Progress in Hormone Research 31:295-319, 1975.
  179. Roselli CE et al. The development of male-oriented behavior in rams. Frontiers in Neuroendocrinology 32(2):164-169, 2011.
  180. Naftolin F et al. Aromatase immunoreactivity in axon terminals of the vertebrate brain. An immunocytochemical study on quail, rat, monkey and human tissues. Neuroendocrinology 63(2):149-155, 1996.
  181. Gorski RA et al. Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Research 148(2):333-346, 1978.
  182. Bakker J, Baum MJ. Role for estradiol in female-typical brain and behavioral sexual differentiation. Frontiers in Neuroendocrinology 29(1):1-16, 2008.
  183. Zuloaga DG et al. The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation. Hormones and Behavior 53(5):613-626, 2008.
  184. Swaab DF. Sexual differentiation of the brain and behavior. Best Practice & Research Clinical Endocrinology & Metabolism 21(3):431-444, 2007.
  185. Wallen K. Hormonal influences on sexually differentiated behavior in nonhuman primates. Frontiers in Neuroendocrinology 26(1):7-26, 2005.
  186. Zuloaga DG et al. The role of androgen receptors in the masculinization of brain and behavior. Hormones and Behavior 53(5):613-626, 2008.
  187. Lenz KM, McCarthy MM. Organized for sex — steroid hormones and the developing hypothalamus. European Journal of Neuroscience 32(12):2096-2104, 2010.
  188. Naftolin F, Ryan KJ, Davies IJ, et al. (1975). The formation of estrogens by central neuroendocrine tissues. Recent Progress in Hormone Research, 31, 295-319.
  189. MacLusky NJ, Naftolin F. (1981). Sexual differentiation of the central nervous system. Science, 211(4488), 1294-1303.
  190. Manning JT, Scutt D, Wilson J, Lewis-Jones DI. The ratio of 2nd to 4th digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen. Hum Reprod 13(11):3000-3004, 1998.
  191. Zheng Z, Cohn MJ. Developmental basis of sexually dimorphic digit ratios. PNAS 108(39):16289-16294, 2011.
  192. American College of Obstetricians and Gynecologists, 'Practice Bulletin No. 175: Ultrasound in Pregnancy,' Obstetrics & Gynecology 128(6):e241-e256, 2016.
  193. Salomon LJ et al., 'ISUOG Practice Guidelines: performance of first-trimester fetal ultrasound scan,' Ultrasound in Obstetrics & Gynecology 41(1):102-113, 2013.
  194. Wilson & Davies, 'The effects of prenatal sex steroid hormones on sexual differentiation of the brain,' PMC3928415
  195. 'INAH 3,' Wikipedia
  196. Tsukahara & Morishita, 'Sexually Dimorphic Formation of the Preoptic Area and the Bed Nucleus of the Stria Terminalis by Neuroestrogens,' Front. Neurosci. (PMC7403479)
  197. Allen LS, Hines M, Shryne JE, Gorski RA. Two sexually dimorphic cell groups in the human brain. J Neurosci. 1989;9(2):497-506.
  198. LeVay S. Science. 1991;253(5023):1034-1037.
  199. Allen LS, Gorski RA. Sex difference in the bed nucleus of the stria terminalis of the human brain. J Comp Neurol. 1990;302(4):697-706.
  200. Lebow MA, Chen A. Mol Psychiatry. 2016;21(4):450-463.
  201. Allen LS, Hines M, Shryne JE, Gorski RA. J Neurosci. 1989;9(2):497-506.
  202. Byne W, Tobet S, Mattiace LA, et al. The interstitial nuclei of the human anterior hypothalamus. Horm Behav. 2001;40(2):86-92.
  203. Gorski RA, Gordon JH, Shryne JE, Southam AM. Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Res. 1978;148(2):333-346.
  204. Paredes RG. Medial preoptic area/anterior hypothalamus and sexual motivation. Scand J Psychol. 2003;44(3):203-212.
  205. Hull EM, Dominguez JM. Sexual behavior in male rodents. Hormones and Behavior 52(1):45-55, 2007.
  206. Simerly RB. Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain. Annual Review of Neuroscience 25:507-536, 2002.
  207. Byne W, et al. Horm Behav. 2001;40(2):86-92. PubMed 11534967.
  208. Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 103(11):4043-4088, 2018.
  209. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews 33(3):378-455, 2012.
  210. Speiser PW et al., Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab 103(11):4043-4088, 2018
  211. Vandenberg LN et al., Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses, Endocr Rev 33(3):378-455, 2012
  212. Livingston, Gretchen, 'They're Waiting Longer, but U.S. Women Today More Likely to Have Children than a Decade Ago,' Pew Research Center, 2018.
  213. OECD Family Database, 'Mean age of women at birth of first child,' SF2.3.
  214. White PC & Speiser PW, 'Congenital adrenal hyperplasia due to 21-hydroxylase deficiency,' Endocr Rev 21(3):245-291, 2000.
  215. Speiser PW et al., J Clin Endocrinol Metab 95(9):4133-4160, 2010.
  216. Speiser PW, Arlt W, Auchus RJ, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043-4088.
  217. NIH/MedlinePlus Genetics: 21-hydroxylase deficiency.
  218. Merke DP, Auchus RJ. Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. New England Journal of Medicine 383(13):1248-1261, 2020.
  219. ATSDR (2022). Toxicological Profile for DDT, DDE, and DDD. U.S. Agency for Toxic Substances and Disease Registry.
  220. Beard, J. (2006). 'DDT and human health.' Science of the Total Environment 355(1–3):78–89.
  221. ATSDR. Toxicological Profile for DDT, DDE, and DDD. U.S. Agency for Toxic Substances and Disease Registry, 2022 — persistence, body burdens, and biological activity.
  222. Cohn, B. A. et al. 'DDT Exposure in Utero and Breast Cancer.' J Clin Endocrinol Metab 100(8):2865–2872, 2015 — in-utero DDT linked to ~4x breast cancer risk decades later.
  223. Eskenazi, B. et al. 'The Pine River Statement: Human Health Consequences of DDT Use.' Environ Health Perspect 117(9):1359–1367, 2009.
  224. Kelce WR, et al. "Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist." Nature 375:581-585, 1995.
  225. You L, Casanova M, Archibeque-Engle S, Sar M, Fan LQ, Heck Hd'A. "Impaired male sexual development in perinatal Sprague-Dawley rats exposed to p,p'-DDE." Toxicological Sciences 45(2):162-173, 1998.
  226. Wania F, Mackay D. Tracking the distribution of persistent organic pollutants. Environ Sci Technol 30(9):390A-396A, 1996.
  227. Mackay D, Shiu WY, Ma KC, Lee SC. Handbook of Physical-Chemical Properties and Environmental Fate for Organic Chemicals, 2nd ed. CRC Press, 2006.
  228. Gore AC, Chappell VA, Fenton SE, et al. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):E1-E150.
  229. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for DDT, DDE, and DDD. U.S. Department of Health and Human Services.
  230. European Food Safety Authority (EFSA). Dioxins and dioxin-like PCBs in food and feed; partitioning into milk/dairy fat.
  231. Standard environmental toxicology: lipophilicity (log Kow) of dioxins/PCBs/DDT drives partitioning into fat tissue and fatty foods.
  232. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139(10):4252-4263, 1998.
  233. vom Saal FS, Welshons WV. Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res 100(1):50-76, 2006.
  234. Kuiper GG, Lemmen JG, Carlsson B, et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139(10), 4252-4263.
  235. Wetherill YB, Akingbemi BT, Kanno J, et al. (2007). In vitro molecular mechanisms of bisphenol A action. Reproductive Toxicology, 24(2), 178-198.
  236. Hayes TB, Khoury V, Narayan A, et al. Atrazine induces complete feminization and chemical castration in male African clawed frogs (Xenopus laevis). PNAS. 2010;107(10):4612-4617.
  237. Sanders R. Pesticide atrazine can turn male frogs into females. Berkeley News / UC Berkeley. March 1, 2010.
  238. Raloff J / C&EN. Atrazine Feminizes Male Frogs. Chemical & Engineering News.
  239. Gore AC et al., Endocrine Reviews 36(6):E1-E150, 2015.
  240. Carroll JS et al., 'Genome-wide analysis of estrogen receptor binding sites,' Nature Genetics 38:1289-1297, 2006.
  241. Lin CY et al., 'Whole-genome cartography of estrogen receptor alpha binding sites,' PLoS Genetics 3(6):e87, 2007.
  242. Baker ME. 'Evolutionary analysis of the steroid receptor superfamily.' (FEBS/comparative endocrinology literature), 2004.
  243. Denslow ND, Sepúlveda MS. 'Ecotoxicological effects of endocrine disrupting compounds on fish reproduction.' Handbook of Experimental Pharmacology 195:333-365, 2012.
  244. National Geographic. How a man produces 1,500 sperm a second (2010).
  245. Amann RP. The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl. 2008;29(5):469-487.
  246. Baker ME. 'Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors.' Molecular and Cellular Endocrinology / FEBS work on steroid-receptor superfamily, 2004.
  247. Denslow ND, Sepulveda MS. 'Ecotoxicological effects of endocrine disrupting compounds on fish reproduction.' Handbook of Experimental Pharmacology 195, 2012.
  248. Di Nardo G et al. Molecular and structural evolution of cytochrome P450 aromatase. (PMC7827799), 2021.
  249. Identification, expression and evolutionary analysis of two cyp19-like genes in amphioxus. (PMC11047327), 2024.
  250. Ankley GT, Johnson RD. Small fish models for identifying and assessing the effects of endocrine-disrupting chemicals. ILAR Journal 45(4):469-483, 2004.
  251. Segner H. Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption. Comparative Biochemistry and Physiology Part C 149(2):187-195, 2009.
  252. Bodwell JE et al. Arsenic disruption of steroid receptor function. Toxicol Sci (2007).
  253. NIEHS Superfund Research Brief 145.
  254. McCarthy, M. M. (2008). 'Estradiol and the developing brain.' Physiological Reviews 88(1):91–124.
  255. Bao, A. M. & Swaab, D. F. (2011). 'Sexual differentiation of the human brain.' Frontiers in Neuroendocrinology 32(2):214–226.
  256. Welsh M et al., Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism, J Clin Invest 118(4):1479-1490, 2008
  257. Hines M, Brain Gender, Oxford University Press, 2004
  258. USDA-AMS National List of Allowed and Prohibited Substances, 7 CFR 205.601 (synthetic substances allowed for use in organic crop production).
  259. USDA NOP, 'Allowed and Prohibited Substances' (National List overview).
  260. Gore AC, Chappell VA, Fenton SE, et al., 'EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals,' Endocrine Reviews 36(6):E1-E150, 2015.
  261. Frye CA, Bo E, Calamandrei G, et al., 'Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems,' Journal of Neuroendocrinology 24(1):144-159, 2012.
  262. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect 111(8):994-1006, 2003.
  263. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33(3):378-455, 2012.
  264. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocrine Reviews 30(4):293-342, 2009.
  265. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. (2009). Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocrine Reviews, 30(4), 293-342.
  266. Gore AC, Chappell VA, Fenton SE, et al. (2015). EDC-2: The Endocrine Society's second scientific statement on endocrine-disrupting chemicals. Endocrine Reviews, 36(6), E1-E150.
  267. Zhu M, Yu X, Ahlberg PE, et al. "A Silurian placoderm with osteichthyan-like marginal jaw bones." Nature 502(7470):188-193, 2013.
  268. Broughton RE, Betancur-R R, Li C, Arratia G, Orti G. "Multi-locus phylogenetic analysis reveals the pattern and tempo of bony fish evolution." PLOS Currents Tree of Life, 2013.
  269. Sanderson et al. 2000; Fan et al., Environ Health Perspect 115:720-727, 2007 (atrazine aromatase induction, not direct ER binding).
  270. Krishnan AV, et al. 'Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving.' Endocrinology 132(6):2279-2286 (1993).
  271. Welshons WV, et al. 'Large effects from small exposures. III. Endocrine mechanisms mediating effects of BPA at levels of human exposure.' Endocrinology 147(6 Suppl):S56-S69 (2006).
  272. Heindel JJ & Vandenberg LN. (2015). Developmental origins of health and disease: a paradigm for understanding disease cause and prevention. Current Opinion in Pediatrics, 27(2), 248-253.
  273. Skinner MK, Manikkam M, Guerrero-Bosagna C. "Epigenetic transgenerational actions of endocrine disruptors." Reproductive Toxicology 31(3):337-343, 2011.
  274. Walker CL, Ho SM. "Developmental reprogramming of cancer susceptibility." Nature Reviews Cancer 12(7):479-486, 2012.
  275. Cirillo, P. M. et al. 'Grandmaternal Perinatal Serum DDT in Relation to Granddaughter Early Menarche and Adult Obesity: Three Generations in the Child Health and Development Studies Cohort.' Cancer Epidemiol Biomarkers Prev 30(8):1480–1487, 2021.
  276. Skinner, M. K. et al. 'Ancestral DDT exposures promote epigenetic transgenerational inheritance of obesity.' BMC Medicine 11:228, 2013.
  277. La Merrill, M. A. et al. 'Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification.' Nature Reviews Endocrinology 16:45–57, 2020.
  278. Cirillo PM et al., 'Grandmaternal Perinatal Serum DDT in Relation to Granddaughter Early Menarche and Adult Obesity,' Cancer Epidemiol Biomarkers Prev 30(8):1480-1488, 2021.
  279. ATSDR, 'Toxicological Profile for DDT, DDE, and DDD,' US Dept of Health and Human Services, 2022.
  280. Markowitz G, Rosner D, 'Deceit and Denial: The Deadly Politics of Industrial Pollution,' University of California Press, 2002.
  281. Michaels D, 'Doubt Is Their Product,' Oxford University Press, 2008.
  282. United Nations DESA, Population Division. 'World Population Prospects 2024' (annual global births ~130-134 million).
  283. GBD 2021 Fertility and Forecasting Collaborators. 'Global fertility in 204 countries and territories, 1950-2021.' The Lancet 403(10440):2057-2099, 2024.
  284. Anway MD et al., 'Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility,' Science 308:1466-1469, 2005 (and Skinner reviews, PMC3068236)
  285. Manikkam M, Skinner MK et al., 'Endocrine Disruptor Induction of Epigenetic Transgenerational Inheritance of Disease' (PMC4262585)
  286. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308(5727):1466-1469.
  287. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 2010;21(4):214-222.
  288. Gore AC et al. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):E1-E150.
  289. Jung YH et al., Recruitment of CTCF to an Fto enhancer is responsible for transgenerational inheritance of BPA-induced obesity, PNAS 119(50):e2214988119, 2022
  290. Chamorro-Garcia R et al., Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice, Environ Health Perspect 121(3):359-366, 2013
  291. Phillips JE, Corces VG, CTCF: master weaver of the genome, Cell 137(7):1194-1211, 2009
  292. Ong CT, Corces VG, CTCF: an architectural protein bridging genome topology and function, Nat Rev Genet 15(4):234-246, 2014
  293. Jung et al., Recruitment of CTCF to an Fto enhancer is responsible for transgenerational inheritance of BPA-induced obesity, PNAS 2022;119(50):e2214988119
  294. Welsh M, Saunders PTK, Fisken M, et al., 'Identification in rats of a programming window for reproductive tract masculinization...,' Journal of Clinical Investigation 118(4):1479-1490, 2008.
  295. Welsh M, Saunders PT, Fisken M, et al. (2008). Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. Journal of Clinical Investigation, 118(4), 1479-1490.
  296. Wilson JD, George FW & Griffin JE. (1981). The hormonal control of sexual development. Science, 211(4488), 1278-1284.
  297. Korolenko AA, Nilsson EE, De Santos S, Skinner MK. Stability of epigenetic transgenerational inheritance of adult-onset disease and parturition abnormalities. PNAS 2026;123(8):e2523071123. DOI 10.1073/pnas.2523071123; PMID 41701841. Twenty rat generations from a single prenatal exposure.
  298. Nilsson EE, et al. Vinclozolin induced epigenetic transgenerational inheritance of pathologies and sperm epimutation biomarkers for specific diseases. PLOS ONE 13(8):e0202662, 2018.
  299. Korolenko AA, Nilsson EE, De Santos S, Skinner MK. Stability of epigenetic transgenerational inheritance of adult-onset disease and parturition abnormalities. PNAS 2026;123(8):e2523071123. DOI 10.1073/pnas.2523071123; PMID 41701841. 20-generation vinclozolin study.
  300. Nilsson EE et al., Vinclozolin induced epigenetic transgenerational inheritance of pathologies and sperm epimutation biomarkers for specific F3 generation disease, PLoS ONE 7(9):e36249, 2012 (PMID 22558438)
  301. Korolenko AA, et al. Multigenerational (~20 generations) effects of vinclozolin. PNAS. 2026;123(8). DOI 10.1073/pnas.2523071123.
  302. Skinner lab. Ten-generation transgenerational study. Environmental Epigenetics. 2025;11(1):dvaf033.
  303. US Department of Labor, National Agricultural Workers Survey (NAWS) data.
  304. Arcury TA, Quandt SA (2021). Environmental Health Threats to Latino Migrant Farmworkers. Annual Review of Public Health 42:117-134 (and 2007 review, 28:345-363).
  305. Inawaka K, Kawabe M, Takahashi S, et al. "Maternal exposure to anti-androgenic compounds, vinclozolin, flutamide and procymidone, has no effects on spermatogenesis and DNA methylation in male rats of subsequent generations." Toxicology and Applied Pharmacology 237(2):178-187, 2009.
  306. Stouder C, Paoloni-Giacobino A. "Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm." Reproduction 139(2):373-379, 2010.
  307. Pool KR, et al. Ancestral lineages of dietary exposure to an endocrine disrupting chemical drive distinct forms of transgenerational subfertility in an insect model. Scientific Reports 14, article s41598-024-67921-x, 2024.
  308. Martini M, et al. Transgenerational impact of DEHP on body weight of Drosophila. Chemosphere 220:1050-1056, 2019.
  309. Heard E, Martienssen RA. Transgenerational epigenetic inheritance: myths and mechanisms. Cell 157(1):95-109, 2014.
  310. Miska EA, Ferguson-Smith AC. Transgenerational inheritance: models and mechanisms of non-DNA sequence-based inheritance. Science 354(6308):59-63, 2016.
  311. Bubenik AB, Pavlansky R. Trophic responses to trauma in growing antlers. Journal of Experimental Zoology 159(3):289-302, 1965.
  312. Bubenik GA. The Antler as a Model in Biomedical Research. In: Horns, Pronghorns, and Antlers. Springer, 1990.
  313. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 150(9):4235-4244, 2009.
  314. Soubry A, Hoyo C, Jirtle RL, Murphy SK. A paternal environmental legacy: evidence for epigenetic inheritance through the male germ line. Prog Biophys Mol Biol 118(1-2):79-85, 2015.
  315. Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK. "Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations." PLOS ONE 8(1):e55387, 2013.
  316. Nilsson EE, Sadler-Riggleman I, Skinner MK. "Environmentally induced epigenetic transgenerational inheritance of disease." Environmental Epigenetics 4(2):dvy016, 2018.
  317. Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science. 2005;308(5727):1466-69.
  318. Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK. Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. PLoS One. 2013;8(1):e55387.
  319. Nilsson EE, Sadler-Riggleman I, Skinner MK. Environmentally induced epigenetic transgenerational inheritance of disease. Environ Epigenet. 2018;4(2):dvy016.
  320. Klaassen CD (ed.) (2018). Casarett and Doull's Toxicology: The Basic Science of Poisons, 9th ed. McGraw-Hill.
  321. Gore AC et al., 'EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals,' Endocr Rev 36(6):E1-E150, 2015.
  322. Schonfelder G et al., 'Parent bisphenol A accumulation in the human maternal-fetal-placental unit,' Environ Health Perspect 110(11):A703-A707, 2002.
  323. Endocrine Reviews homepage (Oxford University Press).
  324. Myers JP, vom Saal FS et al., 'Why public health agencies cannot depend on Good Laboratory Practices as a criterion for selecting data: the case of bisphenol A,' Environmental Health Perspectives 117(3):309-315, 2009.
  325. Vandenberg LN, Colborn T, Hayes TB, et al. 'Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.' Endocrine Reviews 33(3):378-455, 2012.
  326. Doll R, Hill AB. BMJ 2(4682):739-748, 1950.
  327. U.S. Surgeon General. Smoking and Health, 1964.
  328. Fry, D.M. & Toone, C.K. (1981). DDT-Induced Feminization of Gull Embryos. Science 213(4510): 922-924.
  329. PubMed entry, DDT-induced feminization of gull embryos (PMID 7256288).
  330. Mechanisms of Endocrine Disruption with Particular Reference to Occurrence in Avian Wildlife: A Review. Ecotoxicology (Springer).
  331. Lewandowsky S, Mann ME, Bauld L, Hastings G, Loftus EF, 'The Subterranean War on Science,' APS Observer 26(9), 2013.
  332. Aviv R, 'A Valuable Reputation,' The New Yorker, February 10, 2014.
  333. Zoeller RT, Brown TR, Doan LL, et al. Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society. Endocrinology 153(9):4097-4110 (2012).
  334. Guillette LJ Jr et al., 'Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida,' Environmental Health Perspectives 102(8):680-688, 1994.
  335. Rehman A, Phillips J, et al., 'Embryology, Sexual Development,' StatPearls (NCBI Bookshelf), updated 2023.
  336. Fausto-Sterling A, Sexing the Body, Basic Books, 2000.
  337. Jenkins S, Wang J, Eltoum I, Desmond R, Lamartiniere CA (2011). Chronic Oral Exposure to Bisphenol A Results in a Nonmonotonic Dose Response in Mammary Carcinogenesis and Metastasis in MMTV-erbB2 Mice. Environmental Health Perspectives, 119(11), 1539-1546.
  338. Mandrup K et al. (2016). Low-dose effects of bisphenol A on mammary gland development in rats / MMTV-erbB2 mice. Andrology, 4(4), 673-683.
  339. Jenkins S. et al., 'Chronic Oral Exposure to Bisphenol A Results in a Nonmonotonic Dose Response in Mammary Carcinogenesis and Metastasis in MMTV-erbB2 Mice,' Environmental Health Perspectives, 2011 (doses 0, 2.5, 25, 250, 2,500 ug BPA/L).
  340. Vandenberg LN, Colborn T, Hayes TB, et al. (2012). Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews, 33(3), 378-455.
  341. Welshons WV, Thayer KA, Judy BM, et al. (2003). Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environmental Health Perspectives, 111(8), 994-1006.
  342. Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS. "Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity." Environmental Health Perspectives 111(8):994-1006, 2003.
  343. Sinclair AH et al., Nature 346:240-244, 1990.
  344. Alberts B et al., Molecular Biology of the Cell, 6th ed., Garland Science, 2014.
  345. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R, 'Male development of chromosomally female mice transgenic for Sry,' Nature 351:117-121, 1991.
  346. Sinclair AH, Berta P, Palmer MS, et al., 'A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif,' Nature 346:240-244, 1990.
  347. Reyes FI, Boroditsky RS, Winter JS, Faiman C. (1974). Studies on human sexual development. II. Journal of Clinical Endocrinology and Metabolism, 38(4), 612-617.
  348. Hines M. (2010). Sex-related variation in human behavior and the brain. Trends in Cognitive Sciences, 14(10), 448-456.
  349. Swaab DF. Sexual differentiation of the brain and behavior. Best Pract Res Clin Endocrinol Metab. 2007;21(3):431-444.
  350. Bao AM, Swaab DF. Front Neuroendocrinol. 2011;32(2):214-226.
  351. Hutchison VH, Dupré RK. 'Thermoregulation,' in Feder ME, Burggren WW (eds.), Environmental Physiology of the Amphibians, Univ. of Chicago Press (1992).
  352. 'Frog Fable Brought to Boil,' Anthropocene Magazine (2011) — corroborates that frogs actively respond to heating.
  353. Welsh M, Saunders PTK, Fisken M, et al. Identification in rats of a programming window for reproductive tract masculinization. J Clin Invest. 2008;118(4):1479-1490.
  354. Hines M. Gendered development. In: Biology of Sex Differences. 2015;6 (and Hines, Annu Rev Neurosci / handbook chapters on prenatal testosterone and brain sexual differentiation).
  355. Adkins-Regan E. Neuroendocrine contributions to sexual partner preference in birds. Frontiers in Neuroendocrinology 32(2):155-163, 2011.
  356. Frederick P, Jayasena N. Altered pairing behaviour and reproductive success in white ibises exposed to environmentally relevant concentrations of methylmercury. Proceedings of the Royal Society B 278(1713):1851-1857, 2011.